Supreme Court rules in favor of embryonic stem cell research in Brazil

By
May 30, 2008 02:36

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analysis from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later

Brazil's Supreme Court says scientists can conduct research using embryonic stem cells. The research holds the promise of curing Parkinson's disease and diabetes but raises ethical concerns about the limits on human life. Six of the court's 11 justices on Thursday upheld a 2005 law allowing embryonic stem cell research by turning down a petition arguing that the law is unconstitutional because it violates the right to life.

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

RESCUE WORKERS search for survivors and victims in the rubble left after a powerful car bomb destroy
July 16, 2019
U.S. House of Representatives pass resolution in regards to AMIA bombing

By ZACHARY KEYSER

Cookie Settings